Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Arrivo BioVentures

Request full access

Pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care

Cary, United StatesFounded 2015Biotech & Life Sciences

About Arrivo BioVentures

Arrivo BioVentures, LLC is a privately held biopharmaceutical company dedicated to the rapid development of biologics and small molecules aimed at enhancing patient outcomes. The company operates within the pharmaceutical and biotech sectors, primarily serving Pharma Biotech companies that seek alternative methods to expand their pipelines and fund development programs in a capital-constrained environment. Arrivo BioVentures leverages the extensive expertise of its seasoned pharmaceutical and startup professionals to expedite drug development processes, whether it involves reformulating existing products or developing new chemical entities. The company’s business model revolves around in-licensing or acquiring promising drug development projects and funding their progression through clinical stages. Revenue is generated through strategic partnerships, licensing agreements, and potential future sales of successfully developed drugs. Arrivo BioVentures is well-positioned to meet the evolving needs of its clients by providing high-quality, efficient, and fast drug development solutions.

Source: Dealroom company data

At a glance

Status
Operational
Employees
15
Open positions
None listed
Dealroom signal
75.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Patient Care, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2023 $45M $245M Rex Health Ventures · Solas BioVentures · Orlando Health Ventures ↗
SERIES AOther financing May 2016 $49M $196M Jazz Pharmaceuticals · Rex Health Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Arrivo BioVentures website traffic

Latest recorded traffic for Arrivo BioVentures is 1.1K monthly website visits, down 26.7% over the last three months. Arrivo BioVentures's team grew 7.1% over the past year.

Latest monthly visits1.1K 3-month web change-26.7% 1-year team growth+7.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Arrivo BioVentures in the Cary ecosystem

Live from Dealroom

The Arrivo BioVentures office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Jazz Pharmaceuticals
  • Rex Health Ventures
  • Solas BioVentures
  • Orlando Health Ventures
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States87.5%
🇨🇦 Canada12.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Arrivo BioVentures on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arrivo BioVentures’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.